Pasar al contenido principal

EFECTO DEL CONSUMO CRONICO DE TOMATE SOBRE PRESION ARTERIAL Y LA FUNCION ENDOTELIAL DE SUJETOS CON ALTO RIESGO VASCULAR

AGL2010-22319-C03-02

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2010
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario FUNDACIÓ DE RECERCA CLÍNIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Red blood cell eicosapentaenoic acid inversely relates to MRI-assessed carotid plaque lipid core burden in elders at high cardiovascular risk

  • Bargallo, Nuria
  • Gilabert, Rosa
  • Romero-Mamani, Edwin-Saúl
  • Cofán, Montserrat
  • Calder, Philip C.
  • Fitó Colomer, Montserrat
  • Corella, Dolores
  • Salas-Salvadó, Jordi
  • Ruiz-Canela, Miguel
  • Estruch, Ramón
  • Ros, Emilio
  • Sala Vila, Aleix
Supplemental marine omega-3 eicosapentaenoic acid (EPA) has an anti-atherosclerotic effect. Clinical research on EPA supplied by the regular diet and atherosclerosis is scarce. In the framework of the PREvención con DIeta MEDiterránea (PREDIMED) trial, we conducted a cross-sectional study in 161 older individuals at high vascular risk grouped into different stages of carotid atherosclerosis severity, including those without ultrasound-detected atheroma plaque (n = 38), with plaques <2.0 mm thick (n = 65), and with plaques ≥2.0 mm (n = 79). The latter were asked to undergo contrast-enhanced 3T magnetic resonance imaging (MRI) and were subsequently grouped into absence (n = 31) or presence (n = 27) of MRI-detectable plaque lipid, a main feature of unstable atheroma plaques. We determined the red blood cell (RBC) proportion of EPA (a valid marker of long-term EPA intake) at enrolment by gas chromatography. In multivariate models, EPA related inversely to MRI-assessed plaque lipid volume, but not to maximum intima-media thickness of internal carotid artery, plaque burden, or MRI-assessed normalized wall index. The inverse association between EPA and plaque lipid content in patients with advanced atherosclerosis supports the notion that this fatty acid might improve cardiovascular health through stabilization of advanced atheroma plaques., CIBEROBN is an initiative of ISCIII, Spain. This study was funded in part by ISCIII (Spanish Ministry of Economy) through grants RTIC G03/140, RTIC RD 06/0045, Centro Nacional de Investigaciones Cardiovasculares CNIC 06/2007, ISCIII FIS PS09/01292; the Spanish Ministry of Science and Innovation (MICINN): AGL2010-22319-C03-02 and AGL2009-13906-C02-02; Fundació “La Marató de TV3”: 294/C/2015. AS-V holds a Miguel Servet I contract (CP12/03299, Instituto de Salud Carlos III, Spain). The funding sources had no involvement in the study design, data collection, analyses, and interpretation of the data or writing of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prediction of cardiovascular disease by the framingham-REGICOR equation in the high-risk PREDIMED cohort: Impact of the mediterranean diet across different risk strata

  • Amor, A.J.
  • Serra-Mir, M.
  • Martínez-González, M.A.
  • Corella, D.
  • Salas-Salvadó, J.
  • Fitó, Montserrat
  • Estruch, R.
  • Serra-Majem, L.
  • Arós, F.
  • Babio, Nancy
  • Ros, E.
  • Cofán, M.
  • Lecea, O.
  • Rosique Esteban, N.
  • Valls-Pedret, C.
  • Freitas-Simoes, T.M.
  • Doménech, M.
  • Gilabert, R.
  • Sagredo Arce, T.
  • Bertolín-Muñoz, A.
  • Tresserra-Rimbau, A.
  • Jurado-Ruíz, Enrique
  • Salaverría, I.
  • Pages, M.A.
  • Cabré, J.J.
  • Mestres, G.
  • Paris, F.
  • Llauradó, M.
  • Pedret, R.
  • Basells, J.
  • Vizcaino, J.
  • Segarra, R.
  • Sacanella, E.
  • Casas, Ricard
  • Frontera, G.
  • Alonso-Gómez, A.
  • Godoy, D.
  • López-Sabater, M.C.
  • de la Torre, Rafael
  • del Hierro, T.
  • Hernandez-Alonso, P.
  • Giardina, S.
  • Ferreira-Pego, C.
  • Pérez-Cabrera, J.
  • Papandreou, C.
  • Baby, P.
  • Camacho, L.
  • Toledo, E.
  • Casanas Quintana, T.
  • Carratalá-Calvo, A.
  • Buil-Cosiales, P.
  • Rovira, A.
  • Ruiz-Canela, M.
  • Martínez, J. Alfredo
  • Fiol, Miquel
  • Castellote-Bargalló, Ana I.
  • Algorta, J.
  • Álvarez-Pérez, J.
  • Sanjulián, B.
  • Ortega, E.
  • Sánchez-Tainta, A.
  • Díez-Espino, Javier
  • Sánchez-Villegas, A.
  • Ginard, M.
  • Fiol, F.
  • García-Valdueza, M.
  • Marrugat, J.
  • Schröder, H.
  • Molina, N.
  • Maestre, E.
  • Castañer, O.
  • Rovira, A.
  • Farré, M.
  • Sorli, J.V.
  • Ramos, A.
  • García, J.
  • Moñino, M.
  • Santamaría, M.I.
  • Fernández-Rodríguez, M. J.
  • Jover, A.
  • Pérez-Heras, A.
  • Zanon-Moreno, V.
  • Díaz-Benítez, E.M.
  • Carrasco, P.
  • Ortega-Azorín, Carolina
  • Asensio, E.M.
  • Oller, M.
  • Proenza, A.
  • Osma, R.
  • Bargalló, Núria
  • Barragán, Rocío
  • Francés, F.
  • García, M.
  • Romaguera, D.
  • Guillén, M.
  • Márquez, F.
  • González, J.I.
  • Saiz, C.
  • Portillo, María P.
  • Mengual, L.
  • Viñas, C.
  • Bautista-Castaño, Inmaculada
  • de Santamaría, L.
  • Portolés, Olga
  • Giménez, F.J.
  • Coltell, O.
  • Guillem-Saiz, P.
  • Chiva, G.
  • Mata, M.
  • Sorli, M.
  • de Juan, C.
  • Roura, P.
  • Rekondo, J.
  • Belló, M.C.
  • Loma-Osorio, A.
  • Gómez-Gracia, Enrique
  • Warnberg, J.
  • Benítez Pont, R.
  • Bianchi Alba, M.
  • Gómez-Huelgas, R.
  • Gueto Rubio, M.V.
  • Bulló, M.
  • Sáez, G.
  • Yuste, M.C.
  • Martínez, P.
  • Valderas, P.
  • Brau, A.
  • Martínez-González, J.
  • Velasco García, V.
  • Romero, S.
  • de Diego Salas, J.
  • Razquin, C.
  • Baca Osorio, A.
  • Gil Zarzosa, J.
  • Becerra-Tomás, Nerea
  • Guarner, A.
  • Sánchez Luque, J.J.
  • Eguaras, S.
  • Vargas López, E.
  • Ruiz-Gutiérrez, Valentina
  • Ibarrola-Jurado, Nuria
  • Tur, Josep A.
  • García Roselló, J.
  • Perona, Javier S.
  • Vigata López, M.D.
  • Montero Romero, Emilio
  • García-García, M.
  • Isach, A.
  • Basora, J.
  • González, R.
  • Nissensohn, M.
  • Díaz-González, V.
  • Ruano-Rodríguez, C.
  • Ortiz-Andrelluchi, A.P.
  • Macías Gutiérrez, B.
  • Santana-Santana, A.J.
  • Pintó, Xavier
  • de la Cruz, E.
  • García-Arellano, A.
  • Mena, G.
  • Marti, A.
  • Salas-Huetos, A.
  • Díaz-López, A.
  • Arceiz Campo, M.T.
  • Arranz, S.
  • Martín, F.
  • Galera, A.
  • Soler, Y.
  • Trias, F.
  • Elosua, R.
  • Sarasa, I.
  • Quiles, L.
  • Padres, E.
  • Corbella, Emili
  • Muñoz-Aguayo, Daniel
  • Molina, C.
  • Cabezas, C.
  • Martín-Rillo, M.J.
  • Vinyoles, E.
  • Rovira, M.A.
  • Goñi, E.
  • Urtasun Samper, A.
  • Tort, N.
  • Sola, A.
  • García, L.
  • Baena, J.M.
  • Flores, G.
  • Verdú, J.M.
  • Tello, S.
  • Arroyo-Azpa, C.
  • García-Pérez, L.
  • Vazquez, Z.
  • Amat, J.
  • Duaso, I.
  • García, Y.
  • Iglesias, C.
  • Simón, C.
  • Quinzavos, L.
  • Parra, L.
  • Liroz, M.
  • Pascual, V.
  • García de la Noceda Montoy, M.D.
  • Berrade, N.
  • Llopis-Osorio, E.
  • Vila, J.
  • Villanueva Telleria, J.
  • Benavent, J.
  • Clos, J.
  • Goñi, E.
  • Pla, I.
  • Amorós, M.
  • Bonet, M.T.
  • Sanz, E.
  • Extremera-Urabayen, V.
  • Martin Monzón, Maria Teresa
  • Prieto, R.
  • Sánchez, M.S.
  • Altirriba, J.
  • Ruiz-Baixauli, J.
  • Cortés Ugalde, F.
  • Manzano, E.
  • Lamuela-Raventós, Rosa M.
  • Altés, A.
  • Sala-Vila, A.
  • Francisco, S.
  • Riera, C.
Background-The usefulness of cardiovascular disease (CVD) predictive equations in different populations is debatable. We assessed the efficacy of the Framingham-REGICOR scale, validated for the Spanish population, to identify future CVD in participants, who were predefined as being at high-risk in the PREvención con DIeta MEDiterránea (PREDIMED) study-a nutrition-intervention primary prevention trial-and the impact of adherence to the Mediterranean diet on CVD across risk categories. Methods and Results-In a post hoc analysis, we assessed the CVD predictive value of baseline estimated risk in 5966 PREDIMED participants (aged 55-74 years, 57% women; 48% with type 2 diabetes mellitus). Major CVD events, the primary PREDIMED end point, were an aggregate of myocardial infarction, stroke, and cardiovascular death. Multivariate-adjusted Cox regression was used to calculate hazard ratios for major CVD events and effect modification from the Mediterranean diet intervention across risk strata (low, moderate, high, very high). The Framingham-REGICOR classification of PREDIMED participants was 25.1% low risk, 44.5% moderate risk, and 30.4% high or very high risk. During 6-year follow-up, 188 major CVD events occurred. Hazard ratios for major CVD events increased in parallel with estimated risk (2.68, 4.24, and 6.60 for moderate, high, and very high risk), particularly in men (7.60, 13.16, and 15.85, respectively, versus 2.16, 2.28, and 3.51, respectively, in women). Yet among those with low or moderate risk, 32.2% and 74.3% of major CVD events occurred in men and women, respectively. Mediterranean diet adherence was associated with CVD risk reduction regardless of risk strata (P > 0.4 for interaction). Conclusions-Incident CVD increased in parallel with estimated risk in the PREDIMED cohort, but most events occurred in non- high-risk categories, particularly in women. Until predictive tools are improved, promotion of the Mediterranean diet might be useful to reduce CVD independent of baseline risk., This study was funded in part by Instituto de Salud Carlos III (ISCIII) (Spanish Ministry of Economy) through grants RTIC G03/140, RTIC RD 06/0045, Centro Nacional de Investigaciones Cardiovasculares CNIC 06/2007, ISCIII FIS PS09/01292, the Spanish Ministry of Science and Innovation (MICINN) AGL2010‐22319‐C03‐02 and AGL2009‐13906‐C02‐02, and an unrestricted grant from the California Walnut Commission, Peer Reviewed
O2, repositorio institucional de la UOC
Publicación Artículo científico (JournalArticle)

Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: A randomized clinical trial

  • Chiva-Blanch, Gemma
  • urpi, mireia
  • Ros, Emilio
  • llorach, rafael
  • Andres-Lacueva, Cristina
  • Estruch Riba, Ramón
  • Lamuela-Raventos, Rosa M
  • Valderas-Martínez, Palmira
  • Casas, Rosa
  • Arranz, Sara
  • Marisa, Guillén
Background & aims. Epidemiological data suggest that moderate red wine consumption reduces cardiovascular mortality and the incidence of diabetes. However, whether these effects are due to ethanol or to non-alcoholic components of red wine still remains unknown. The aim of the present study was to compare the effects of moderate consumption of red wine, dealcoholized red wine, and gin on glucose metabolism and the lipid profile. Methods. Sixty-seven men at high cardiovascular risk were randomized in a crossover trial. After a run-in period, all received each of red wine (30 g alcohol/d), the equivalent amount of dealcoholized red wine, and gin (30 g alcohol/d) for 4 week periods, in a randomized order. Fasting plasma glucose and insulin, homeostasis model assessment of insulin resistance (HOMA-IR), plasma lipoproteins, apolipoproteins and adipokines were determined at baseline and after each intervention. Results. Fasting glucose remained constant throughout the study, while mean adjusted plasma insulin and HOMA-IR decreased after red wine and dealcoholized red wine. HDL cholesterol, Apolipoprotein A-I and A-II increased after red wine and gin. Lipoprotein(a) decreased after the red wine intervention. Conclusions. These results support a beneficial effect of the non-alcoholic fraction of red wine (mainly polyphenols) on insulin resistance, conferring greater protective effects on cardiovascular disease to red wine than other alcoholic beverages.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Red blood cell eicosapentaenoic acid inversely relates to MRI-assessed carotid plaque lipid core burden in elders at high cardiovascular risk

  • Bargallo, Nuria
  • Gilabert, Rosa
  • Romero-Mamani, Edwin-Saúl
  • Cofán, Montserrat
  • Calder, Philip C.
  • Fitó Colomer, Montserrat
  • Corella, Dolores
  • Salas-Salvadó, Jordi
  • Ruiz-Canela, Miguel
  • Estruch, Ramón
  • Ros, Emilio
  • Sala Vila, Aleix
Supplemental marine omega-3 eicosapentaenoic acid (EPA) has an anti-atherosclerotic effect. Clinical research on EPA supplied by the regular diet and atherosclerosis is scarce. In the framework of the PREvención con DIeta MEDiterránea (PREDIMED) trial, we conducted a cross-sectional study in 161 older individuals at high vascular risk grouped into different stages of carotid atherosclerosis severity, including those without ultrasound-detected atheroma plaque (n = 38), with plaques <2.0 mm thick (n = 65), and with plaques ≥2.0 mm (n = 79). The latter were asked to undergo contrast-enhanced 3T magnetic resonance imaging (MRI) and were subsequently grouped into absence (n = 31) or presence (n = 27) of MRI-detectable plaque lipid, a main feature of unstable atheroma plaques. We determined the red blood cell (RBC) proportion of EPA (a valid marker of long-term EPA intake) at enrolment by gas chromatography. In multivariate models, EPA related inversely to MRI-assessed plaque lipid volume, but not to maximum intima-media thickness of internal carotid artery, plaque burden, or MRI-assessed normalized wall index. The inverse association between EPA and plaque lipid content in patients with advanced atherosclerosis supports the notion that this fatty acid might improve cardiovascular health through stabilization of advanced atheroma plaques., CIBEROBN is an initiative of ISCIII, Spain. This study was funded in part by ISCIII (Spanish Ministry of Economy) through grants RTIC G03/140, RTIC RD 06/0045, Centro Nacional de Investigaciones Cardiovasculares CNIC 06/2007, ISCIII FIS PS09/01292; the Spanish Ministry of Science and Innovation (MICINN): AGL2010-22319-C03-02 and AGL2009-13906-C02-02; Fundació “La Marató de TV3”: 294/C/2015. AS-V holds a Miguel Servet I contract (CP12/03299, Instituto de Salud Carlos III, Spain). The funding sources had no involvement in the study design, data collection, analyses, and interpretation of the data or writing of the manuscript.